chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: rash all over body that looks  like red dots; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (rash all over body that looks  like red dots) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced RASH ERYTHEMATOUS (rash all over body that looks  like red dots). At the time of the report, RASH ERYTHEMATOUS (rash all over body that looks  like red dots) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant Medications were reported. No Treatment Information Provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Dermatitis contact, Intentional product use issue
Clinical narrative: scheduled to receive second dose on 28Apr2021 which is on day 41 after first dose; Poison ivy around eyes; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS CONTACT (Poison ivy around eyes) and INTENTIONAL PRODUCT USE ISSUE (scheduled to receive second dose on 28Apr2021 which is on day 41 after first dose) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concomitant products included SIMVASTATIN and LEVOTHYROXINE for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced DERMATITIS CONTACT (Poison ivy around eyes). On 14-Apr-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (scheduled to receive second dose on 28Apr2021 which is on day 41 after first dose). The patient was treated with PREDNISONE (oral) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DERMATITIS CONTACT (Poison ivy around eyes) outcome was unknown and INTENTIONAL PRODUCT USE ISSUE (scheduled to receive second dose on 28Apr2021 which is on day 41 after first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: followup received on 23-apr-2021: concomitant and treatment medications,new events were added
Sex: M
Vaccine: COVID19
Symptoms: Joint swelling, Mass, Swelling
Clinical narrative: Bump on elbow; bump on elbow, half size of golf ball; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Bump on elbow), MASS (bump on elbow, half size of golf ball) and SWELLING (Swelling) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013m20a) for COVID-19 immunization.     Concurrent medical conditions included Lung disease. Concomitant products included OXYGEN for Supplementation therapy.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced JOINT SWELLING (Bump on elbow), MASS (bump on elbow, half size of golf ball) and SWELLING (Swelling). At the time of the report, JOINT SWELLING (Bump on elbow), MASS (bump on elbow, half size of golf ball) and SWELLING (Swelling) outcome was unknown.            The patient stated that he uses more supplemental oxygen.  Treatment medication information was not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate irregular, Vaccination site rash, Vaccination site reaction
Clinical narrative: irregular heart beat; "COVID arm" with a rash that was hot and itchy and kept spreading; "COVID arm" with a rash that was hot and itchy and kept spreading; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH ("COVID arm" with a rash that was hot and itchy and kept spreading), HEART RATE IRREGULAR (irregular heart beat) and VACCINATION SITE REACTION ("COVID arm" with a rash that was hot and itchy and kept spreading) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031l20a) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced VACCINATION SITE RASH ("COVID arm" with a rash that was hot and itchy and kept spreading) and VACCINATION SITE REACTION ("COVID arm" with a rash that was hot and itchy and kept spreading). On 02-Apr-2021, the patient experienced HEART RATE IRREGULAR (irregular heart beat). On 31-Mar-2021, VACCINATION SITE RASH ("COVID arm" with a rash that was hot and itchy and kept spreading) and VACCINATION SITE REACTION ("COVID arm" with a rash that was hot and itchy and kept spreading) had resolved. On 02-Apr-2021, HEART RATE IRREGULAR (irregular heart beat) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided. No treatment medication was provided.
Sex: M
Vaccine: COVID19
Symptoms: Inflammation
Clinical narrative: High levels of inflammation in blood tests, levels went up; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (High levels of inflammation in blood tests, levels went up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLAMMATION (High levels of inflammation in blood tests, levels went up). At the time of the report, INFLAMMATION (High levels of inflammation in blood tests, levels went up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.    This case was linked to MOD-2021-075456 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Email from reporter, sex of patient corrected to female, requests call from Safety in order to relay what happened in detail, then will decide if want to involve doctors/hospital staff.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Extrasystoles, Fatigue, Injection site mass
Clinical narrative: weakness; tired; fever of 100f; heart went out of rhythm for 20 min; hard ball at the injection site over 2 weeks; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHENIA (weakness), EXTRASYSTOLES (heart went out of rhythm for 20 min), INJECTION SITE MASS (hard ball at the injection site over 2 weeks), FATIGUE (tired) and PYREXIA (fever of 100f) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Myasthenia gravis.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), EXTRASYSTOLES (heart went out of rhythm for 20 min), INJECTION SITE MASS (hard ball at the injection site over 2 weeks), FATIGUE (tired) and PYREXIA (fever of 100f). At the time of the report, ASTHENIA (weakness), EXTRASYSTOLES (heart went out of rhythm for 20 min), INJECTION SITE MASS (hard ball at the injection site over 2 weeks), FATIGUE (tired) and PYREXIA (fever of 100f) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: 37.8 (normal) 100F (37.8 degree Celsius).         no treatment and concomitant product was reported. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: weakness; tired; fever of 100f; heart went out of rhythm for 20 min; hard ball at the injection site over 2 weeks; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHENIA (weakness), EXTRASYSTOLES (heart went out of rhythm for 20 min), INJECTION SITE MASS (hard ball at the injection site over 2 weeks), FATIGUE (tired) and PYREXIA (fever of 100f) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Myasthenia gravis.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), EXTRASYSTOLES (heart went out of rhythm for 20 min), INJECTION SITE MASS (hard ball at the injection site over 2 weeks), FATIGUE (tired) and PYREXIA (fever of 100f). At the time of the report, ASTHENIA (weakness), EXTRASYSTOLES (heart went out of rhythm for 20 min), INJECTION SITE MASS (hard ball at the injection site over 2 weeks), FATIGUE (tired) and PYREXIA (fever of 100f) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: 37.8 (normal) 100F (37.8 degree Celsius).         no treatment and concomitant product was reported. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Swollen lips; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swollen lips) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 082L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LIP SWELLING (Swollen lips). On 18-Jan-2021, LIP SWELLING (Swollen lips) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant product use was not provided by the reporter.  No treatment medication was reported for this event.   This case was linked to US-MODERNATX, INC.-MOD-2021-074846 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074846:Second dose case
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Nervousness, Pyrexia
Clinical narrative: Dizziness; Room spinning; Increasing nervousness/trembling; Nausea; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), VERTIGO (Room spinning), NERVOUSNESS (Increasing nervousness/trembling), NAUSEA (Nausea) and HEADACHE (Headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma. Concomitant products included MONTELUKAST SODIUM (SINGULAIR) and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced DIZZINESS (Dizziness), VERTIGO (Room spinning), NERVOUSNESS (Increasing nervousness/trembling), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIMENHYDRINATE (DRAMAMINE) at an unspecified dose and frequency. On 23-Mar-2021, PYREXIA (Fever) outcome was unknown. At the time of the report, DIZZINESS (Dizziness), VERTIGO (Room spinning), NERVOUSNESS (Increasing nervousness/trembling), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant product included Ventolin inhaler.   This case was linked to US-MODERNATX, INC.-MOD-2021-074878 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074878:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Dizziness; Room spinning; Increasing nervousness/trembling; Nausea; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), VERTIGO (Room spinning), NERVOUSNESS (Increasing nervousness/trembling), NAUSEA (Nausea) and HEADACHE (Headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma. Concomitant products included MONTELUKAST SODIUM (SINGULAIR) and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced DIZZINESS (Dizziness), VERTIGO (Room spinning), NERVOUSNESS (Increasing nervousness/trembling), NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIMENHYDRINATE (DRAMAMINE) at an unspecified dose and frequency. On 23-Mar-2021, PYREXIA (Fever) outcome was unknown. At the time of the report, DIZZINESS (Dizziness), VERTIGO (Room spinning), NERVOUSNESS (Increasing nervousness/trembling), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant product included Ventolin inhaler.   This case was linked to US-MODERNATX, INC.-MOD-2021-074878 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074878:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscular weakness, Musculoskeletal discomfort
Clinical narrative: weakness in the legs; back problems; headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (weakness in the legs), MUSCULOSKELETAL DISCOMFORT (back problems) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Thyroid disorder NOS, Hypertension and Pain.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced MUSCULAR WEAKNESS (weakness in the legs), MUSCULOSKELETAL DISCOMFORT (back problems) and HEADACHE (headache). At the time of the report, MUSCULAR WEAKNESS (weakness in the legs), MUSCULOSKELETAL DISCOMFORT (back problems) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Product was included Blood pressure, diabetes, thyroid and pain medications. No treatment information was included.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Migraine, Pain in extremity
Clinical narrative: migraine; shooting chest pain; shoulder pain; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine), CHEST PAIN (shooting chest pain), ARTHRALGIA (shoulder pain) and PAIN IN EXTREMITY (sore arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced MIGRAINE (migraine), CHEST PAIN (shooting chest pain), ARTHRALGIA (shoulder pain) and PAIN IN EXTREMITY (sore arm). At the time of the report, MIGRAINE (migraine), CHEST PAIN (shooting chest pain), ARTHRALGIA (shoulder pain) and PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported. No treatment information was reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Skin discolouration
Clinical narrative: Felt strange; Palms turned orange; Palms turned orange; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of SKIN DISCOLOURATION (Palms turned orange), FEELING ABNORMAL (Felt strange) and the second episode of SKIN DISCOLOURATION (Palms turned orange) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's medical history information was not provided.  Concomitant products included LISINOPRIL, HYDROCHLOROTHIAZIDE and ATORVASTATIN for an unknown indication.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced the first episode of SKIN DISCOLOURATION (Palms turned orange). On an unknown date, the patient experienced FEELING ABNORMAL (Felt strange) and the second episode of SKIN DISCOLOURATION (Palms turned orange). At the time of the report, FEELING ABNORMAL (Felt strange) outcome was unknown and last episode of SKIN DISCOLOURATION (Palms turned orange) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reportedly, first episode of skin discoloration was observed couple of hours after receiving the vaccine and went away in 3-4mins. Second episode was observed 2-3 days later and went away by itself in 1 min.   No information regarding treatment medication was provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (some vaccine leaked out) and DEVICE CONNECTION ISSUE (needle wasn't connected to the syringe) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced UNDERDOSE (some vaccine leaked out) and DEVICE CONNECTION ISSUE (needle wasn't connected to the syringe). On 13-Apr-2021, UNDERDOSE (some vaccine leaked out) and DEVICE CONNECTION ISSUE (needle wasn't connected to the syringe) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment information was provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: hot flash from head to toe; sweating to the point where my clothes are wet; running a fever; chills; joint ache; headache; very tired; nausea; no appetite; soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm), HOT FLUSH (hot flash from head to toe), HYPERHIDROSIS (sweating to the point where my clothes are wet), PYREXIA (running a fever) and CHILLS (chills) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm). On 06-Apr-2021, the patient experienced HOT FLUSH (hot flash from head to toe), HYPERHIDROSIS (sweating to the point where my clothes are wet), PYREXIA (running a fever), CHILLS (chills), ARTHRALGIA (joint ache), HEADACHE (headache), FATIGUE (very tired), NAUSEA (nausea) and DECREASED APPETITE (no appetite). On 06-Apr-2021, HOT FLUSH (hot flash from head to toe), HYPERHIDROSIS (sweating to the point where my clothes are wet), PYREXIA (running a fever) and CHILLS (chills) had resolved. On 08-Apr-2021, PAIN IN EXTREMITY (soreness in arm) had resolved. On 09-Apr-2021, NAUSEA (nausea) and DECREASED APPETITE (no appetite) had resolved. At the time of the report, ARTHRALGIA (joint ache), HEADACHE (headache) and FATIGUE (very tired) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took advil in the first evening for the arm pain and Stayed hydrated
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Hyperhidrosis, Nausea, Pain in extremity, Pyrexia
Clinical narrative: hot flash from head to toe; sweating to the point where my clothes are wet; running a fever; chills; joint ache; headache; very tired; nausea; no appetite; soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm), HOT FLUSH (hot flash from head to toe), HYPERHIDROSIS (sweating to the point where my clothes are wet), PYREXIA (running a fever) and CHILLS (chills) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm). On 06-Apr-2021, the patient experienced HOT FLUSH (hot flash from head to toe), HYPERHIDROSIS (sweating to the point where my clothes are wet), PYREXIA (running a fever), CHILLS (chills), ARTHRALGIA (joint ache), HEADACHE (headache), FATIGUE (very tired), NAUSEA (nausea) and DECREASED APPETITE (no appetite). On 06-Apr-2021, HOT FLUSH (hot flash from head to toe), HYPERHIDROSIS (sweating to the point where my clothes are wet), PYREXIA (running a fever) and CHILLS (chills) had resolved. On 08-Apr-2021, PAIN IN EXTREMITY (soreness in arm) had resolved. On 09-Apr-2021, NAUSEA (nausea) and DECREASED APPETITE (no appetite) had resolved. At the time of the report, ARTHRALGIA (joint ache), HEADACHE (headache) and FATIGUE (very tired) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took advil in the first evening for the arm pain and Stayed hydrated
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product availability issue
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of inappropriate schedule of product administration (2nd vaccination mistakenly scheduled for the Pfizer shot) and product availability issue (2nd vaccination mistakenly scheduled for the Pfizer shot) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Feb 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Apr 13, 2021, patient experienced inappropriate schedule of product administration (2nd vaccination mistakenly scheduled for the Pfizer shot) and product availability issue (2nd vaccination mistakenly scheduled for the Pfizer shot). At the time of the report, inappropriate schedule of product administration (2nd vaccination mistakenly scheduled for the Pfizer shot) and product availability issue (2nd vaccination mistakenly scheduled for the Pfizer shot) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant product use and treatment information not reported.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Cold sweat, Decreased appetite, Dysmorphism, Dyspnoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid pulse), DYSMORPHISM (drooping face), DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite) and COLD SWEAT (cold sweat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007321A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced HEART RATE INCREASED (rapid pulse), DYSMORPHISM (drooping face), DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite), COLD SWEAT (cold sweat), HYPERSOMNIA (slept for 13 hours), MUSCULOSKELETAL PAIN (calves and thighs hurt for 4 days), PYREXIA (slightly feverish), ARTHRALGIA (severe join pain) and FATIGUE (fatigue). The patient was treated with IBUPROFEN ongoing since an unknown date for Pain, at a dose of UNK dosage form. On 21-Mar-2021, HEART RATE INCREASED (rapid pulse), DYSMORPHISM (drooping face), DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite), COLD SWEAT (cold sweat), HYPERSOMNIA (slept for 13 hours), PYREXIA (slightly feverish), ARTHRALGIA (severe join pain) and FATIGUE (fatigue) had resolved. On 24-Mar-2021, MUSCULOSKELETAL PAIN (calves and thighs hurt for 4 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took ibuprofen to help with thighs and calves hurting. No concomitant medication information were provided   This case was linked to MOD-2021-073078 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Heart rate increased, Hypersomnia, Musculoskeletal pain, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid pulse), DYSMORPHISM (drooping face), DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite) and COLD SWEAT (cold sweat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007321A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced HEART RATE INCREASED (rapid pulse), DYSMORPHISM (drooping face), DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite), COLD SWEAT (cold sweat), HYPERSOMNIA (slept for 13 hours), MUSCULOSKELETAL PAIN (calves and thighs hurt for 4 days), PYREXIA (slightly feverish), ARTHRALGIA (severe join pain) and FATIGUE (fatigue). The patient was treated with IBUPROFEN ongoing since an unknown date for Pain, at a dose of UNK dosage form. On 21-Mar-2021, HEART RATE INCREASED (rapid pulse), DYSMORPHISM (drooping face), DYSPNOEA (shortness of breath), DECREASED APPETITE (loss of appetite), COLD SWEAT (cold sweat), HYPERSOMNIA (slept for 13 hours), PYREXIA (slightly feverish), ARTHRALGIA (severe join pain) and FATIGUE (fatigue) had resolved. On 24-Mar-2021, MUSCULOSKELETAL PAIN (calves and thighs hurt for 4 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took ibuprofen to help with thighs and calves hurting. No concomitant medication information were provided   This case was linked to MOD-2021-073078 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Menstruation irregular, Pain in extremity, Pruritus, Vaccination site pain
Clinical narrative: left side breast/rib pain; left leg pain; itching all over; irregular menstrual cycle; left arm pain at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (left side breast/rib pain), PAIN IN EXTREMITY (left leg pain), PRURITUS (itching all over), MENSTRUATION IRREGULAR (irregular menstrual cycle) and VACCINATION SITE PAIN (left arm pain at the site of the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included METOPROLOL for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced BREAST PAIN (left side breast/rib pain), PAIN IN EXTREMITY (left leg pain), PRURITUS (itching all over), MENSTRUATION IRREGULAR (irregular menstrual cycle) and VACCINATION SITE PAIN (left arm pain at the site of the injection). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form as required; IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at a dose of 1 dosage form as required and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form as required. At the time of the report, BREAST PAIN (left side breast/rib pain), PAIN IN EXTREMITY (left leg pain) and VACCINATION SITE PAIN (left arm pain at the site of the injection) was resolving and PRURITUS (itching all over) and MENSTRUATION IRREGULAR (irregular menstrual cycle) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was noted by the patient that the itching (pruritus) still persists but other symptoms have improved in the past few weeks.  The patient also noted that her menstrual cycles were regular prior to the vaccine and now continue to be irregular since receiving the vaccination.  The patient also stated that she was planning to discuss her events with her HCP.  Further clinical course is unknown/not reported at this time.
Sex: F
Vaccine: COVID19
Symptoms: Glossodynia, Tongue blistering
Clinical narrative: Blister in the back on tongue; Painful when tongue is moved; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE BLISTERING (Blister in the back on tongue) and GLOSSODYNIA (Painful when tongue is moved) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TONGUE BLISTERING (Blister in the back on tongue) and GLOSSODYNIA (Painful when tongue is moved). At the time of the report, TONGUE BLISTERING (Blister in the back on tongue) and GLOSSODYNIA (Painful when tongue is moved) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use not reported.   Treatment information not reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pain in extremity
Clinical narrative: Perfect heart  on arm after 1st dose; Black and blue on arm after 1st dose; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Perfect heart  on arm after 1st dose) and CONTUSION (Black and blue on arm after 1st dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036a21a) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Perfect heart  on arm after 1st dose) and CONTUSION (Black and blue on arm after 1st dose). At the time of the report, PAIN IN EXTREMITY (Perfect heart  on arm after 1st dose) and CONTUSION (Black and blue on arm after 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication  and treatment information were reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: When she get out the banded she notes a red spot and it where hurt for 2 days; When she get out the banded she notes a red spot and it where hurt for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (When she get out the banded she notes a red spot and it where hurt for 2 days) and VACCINATION SITE PAIN (When she get out the banded she notes a red spot and it where hurt for 2 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (When she get out the banded she notes a red spot and it where hurt for 2 days) and VACCINATION SITE PAIN (When she get out the banded she notes a red spot and it where hurt for 2 days). At the time of the report, VACCINATION SITE ERYTHEMA (When she get out the banded she notes a red spot and it where hurt for 2 days) and VACCINATION SITE PAIN (When she get out the banded she notes a red spot and it where hurt for 2 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fall, Product dose omission issue
Clinical narrative: unable to get the 2nd dose; dizziness; Falling; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), FALL (Falling) and PRODUCT DOSE OMISSION ISSUE (unable to get the 2nd dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hard of hearing.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced DIZZINESS (dizziness) and FALL (Falling). On 12-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (unable to get the 2nd dose). On 12-Apr-2021, PRODUCT DOSE OMISSION ISSUE (unable to get the 2nd dose) had resolved. At the time of the report, DIZZINESS (dizziness) and FALL (Falling) outcome was unknown. Not Provided          No concomitants products were reported.  No treatment information was reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Chills, Fatigue, Feeling cold
Clinical narrative: left breast was hurting; chills; body was tired, sensation that wanted to go to bed and tuck in to be warm; was cold; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (was cold), BREAST PAIN (left breast was hurting), CHILLS (chills) and FATIGUE (body was tired, sensation that wanted to go to bed and tuck in to be warm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypercholesterolemia and Blood pressure high. Concomitant products included METFORMIN and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced FEELING COLD (was cold), CHILLS (chills) and FATIGUE (body was tired, sensation that wanted to go to bed and tuck in to be warm). On 12-Apr-2021, the patient experienced BREAST PAIN (left breast was hurting). On 12-Apr-2021, FEELING COLD (was cold), CHILLS (chills) and FATIGUE (body was tired, sensation that wanted to go to bed and tuck in to be warm) had resolved. On 13-Apr-2021, BREAST PAIN (left breast was hurting) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Additional concomitant medication included a waterpill, cholesterol medication and high blood pressure medication. These were not further specified.   It was noted by the reporter that the patient did not take medication to treat symptoms and that the patient no longer has symptoms.   At this time, no adverse events were reported after the second dose of the vaccine.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: aches; chills; Fever 101.3 F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches), CHILLS (chills) and PYREXIA (Fever 101.3 F) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (aches), CHILLS (chills) and PYREXIA (Fever 101.3 F). At the time of the report, PAIN (aches), CHILLS (chills) and PYREXIA (Fever 101.3 F) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.    Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: TCR. Follow up is NNI.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Confusional state, Decreased appetite, Dizziness, Headache
Clinical narrative: shaky; dizziness; confusion; could not eat for couple of days; missed three days at work; fever; nauseated; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (shaky), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), DECREASED APPETITE (could not eat for couple of days) and IMPAIRED WORK ABILITY (missed three days at work) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NERVOUSNESS (shaky), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), DECREASED APPETITE (could not eat for couple of days), IMPAIRED WORK ABILITY (missed three days at work), PYREXIA (fever), NAUSEA (nauseated), HEADACHE (headache) and CHILLS (chills). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, NERVOUSNESS (shaky), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), DECREASED APPETITE (could not eat for couple of days), IMPAIRED WORK ABILITY (missed three days at work), PYREXIA (fever), NAUSEA (nauseated), HEADACHE (headache) and CHILLS (chills) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.   This case was linked to MOD-2021-041085 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Nausea, Nervousness, Pyrexia
Clinical narrative: shaky; dizziness; confusion; could not eat for couple of days; missed three days at work; fever; nauseated; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (shaky), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), DECREASED APPETITE (could not eat for couple of days) and IMPAIRED WORK ABILITY (missed three days at work) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NERVOUSNESS (shaky), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), DECREASED APPETITE (could not eat for couple of days), IMPAIRED WORK ABILITY (missed three days at work), PYREXIA (fever), NAUSEA (nauseated), HEADACHE (headache) and CHILLS (chills). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, NERVOUSNESS (shaky), DIZZINESS (dizziness), CONFUSIONAL STATE (confusion), DECREASED APPETITE (could not eat for couple of days), IMPAIRED WORK ABILITY (missed three days at work), PYREXIA (fever), NAUSEA (nauseated), HEADACHE (headache) and CHILLS (chills) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.   This case was linked to MOD-2021-041085 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: residual redness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (residual redness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040a21a and 024m20a) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ROSUVASTATIN for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ERYTHEMA (residual redness). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, ERYTHEMA (residual redness) outcome was unknown.            This case was linked to MOD-2021-073770 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: missed the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed the second dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was reported.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Insomnia, Musculoskeletal stiffness
Clinical narrative: still are not feeling quite back to normal; lump the size of a softball, that was injected; fatigue; chills; fever; a swollen armpit under the arm that was injected; body aches; could not bend fingers; hard time sleeping that night due to fever; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (could not bend fingers), INSOMNIA (hard time sleeping that night due to fever), FEELING ABNORMAL (still are not feeling quite back to normal), VACCINATION SITE LYMPHADENOPATHY (lump the size of a softball, that was injected) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (could not bend fingers), INSOMNIA (hard time sleeping that night due to fever), VACCINATION SITE LYMPHADENOPATHY (lump the size of a softball, that was injected), FATIGUE (fatigue), CHILLS (chills), PYREXIA (fever), VACCINATION SITE SWELLING (a swollen armpit under the arm that was injected) and MYALGIA (body aches). On 12-Apr-2021, the patient experienced FEELING ABNORMAL (still are not feeling quite back to normal). At the time of the report, MUSCULOSKELETAL STIFFNESS (could not bend fingers), INSOMNIA (hard time sleeping that night due to fever), FEELING ABNORMAL (still are not feeling quite back to normal), VACCINATION SITE LYMPHADENOPATHY (lump the size of a softball, that was injected), FATIGUE (fatigue), CHILLS (chills), PYREXIA (fever), VACCINATION SITE SWELLING (a swollen armpit under the arm that was injected) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-073728 (E2B Linked Report).; Sender's Comments:  MOD21-073728:CROSSLINKED